BioCentury
ARTICLE | Company News

Stellar, Matritech bladder diagnostic deal

October 24, 2003 7:00 AM UTC

Canadian specialty pharma company Stellar (TSE:YYS; SLRXF) received exclusive rights to market NMPS's NMP22 BladderChek test to diagnose and monitor bladder cancer. BladderChek is approved by FDA for ...